Dying Too Soon: Excess Mortality in Severe Mental Illness

被引:66
作者
de Mooij, Liselotte D. [1 ]
Kikkert, Martijn [1 ]
Theunissen, Jan [2 ]
Beekman, Aartjan T. F. [2 ,3 ]
de Haan, Lieuwe [1 ,4 ]
Duurkoop, Pim W. R. A. [1 ]
Van, Henricus L. [1 ]
Dekker, Jack J. M. [1 ,5 ]
机构
[1] Arkin Mental Hlth Inst, Dept Res, Amsterdam, Netherlands
[2] GGZ InGeest Mental Hlth Inst, Dept Res, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands
[4] Acad Med Ctr, Dept Psychiat, Amsterdam, Netherlands
[5] Vrije Univ Amsterdam, Med Ctr, Dept Clin Psychol, Amsterdam, Netherlands
来源
FRONTIERS IN PSYCHIATRY | 2019年 / 10卷
关键词
psychoses; cardiovascular disease; standardised mortality ratios; smoking; metabolic syndrome; life expectancy; PSYCHIATRIC RATING-SCALE; ANTIPSYCHOTIC POLYPHARMACY; CANCER-MORTALITY; LIFE EXPECTANCY; SCHIZOPHRENIA; SUICIDE; RISK; PREVALENCE; PEOPLE; DISORDERS;
D O I
10.3389/fpsyt.2019.00855
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Aims: We aimed to identify baseline predictors of mortality in patients with a severe mental illness (SMI) over a 6-year period and to describe mortality rates as standardised mortality ratios (SMRs). We hypothesised that cardiovascular diseases, older age, cigarette smoking, more severe psychiatric symptoms and more severe psychotropic side effects, and alcohol or drug use were independent risk factors for mortality. Method: Medical examinations were conducted at baseline in a cohort of 322 SMI patients. SMRs were estimated after 6 years and an evaluation was made of the impact of a wide range of variables on survival time. Results: Almost 11% of the SMI patients had died at the end of the study period. All-cause SMRs were 4.51 (95% CI 3.07-5.95) for all SMI patients (4.89, 95% CI 2.97-6.80 for men, and 3.94, 95% CI 1.78-6.10 for women). Natural causes accounted for 86% of excess mortality and unnatural causes for 14%. Cardiovascular disease was a major contributor to this excess mortality. Multivariate Cox regression analyses showed that premature death was associated with a longer history of tobacco use (HR: 1.03, 95% CI 1.02-1.03) and more severe symptoms of disorganisation (HR: 2.36, 95% CI 2.21-2.52). Conclusions: The high SMR and the incidence of cardiovascular disease-related death in SMI patients in our study justify concern. This study underscores the urgent need for interventions to reduce excess mortality in patients with SMI.
引用
收藏
页数:10
相关论文
共 81 条
  • [21] COMPONENT STRUCTURE OF THE EXPANDED BRIEF PSYCHIATRIC RATING-SCALE (BPRS-E)
    DINGEMANS, PMAJ
    LINSZEN, DH
    LENIOR, ME
    SMEETS, RMW
    [J]. PSYCHOPHARMACOLOGY, 1995, 122 (03) : 263 - 267
  • [22] Attitudes and Practices of Euthanasia and Physician-Assisted Suicide in the United States, Canada, and Europe
    Emanuel, Ezekiel J.
    Onwuteaka-Philipsen, Bregje D.
    Urwin, John W.
    Cohen, Joachim
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (01): : 79 - 90
  • [23] Felker B, 1996, PSYCHIAT SERV, V47, P1356
  • [24] The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness
    Firth, Joseph
    Siddiqi, Najma
    Koyanagi, Ai
    Siskind, Dan
    Rosenbaum, Simon
    Galletly, Cherrie
    Allan, Stephanie
    Caneo, Constanza
    Carney, Rebekah
    Carvalho, Andre F.
    Chatterton, Mary Lou
    Correll, Christoph U.
    Curtis, Jackie
    Gaughran, Fiona
    Heald, Adrian
    Hoare, Erin
    Jackson, Sarah E.
    Kisely, Steve
    Lovell, Karina
    Maj, Mario
    McGorry, Patrick D.
    Mihalopoulos, Cathrine
    Myles, Hannah
    O'Donoghue, Brian
    Pillinger, Toby
    Sarris, Jerome
    Schuch, Felipe B.
    Shiers, David
    Smith, Lee
    Solmi, Marco
    Suetani, Shuichi
    Taylor, Johanna
    Teasdale, Scott B.
    Thornicroft, Graham
    Torous, John
    Usherwood, Tim
    Vancampfort, Davy
    Veronese, Nicola
    Ward, Philip B.
    Yung, Alison R.
    Killackey, Eoin
    Stubbs, Brendon
    [J]. LANCET PSYCHIATRY, 2019, 6 (08): : 675 - 712
  • [25] Critical review of antipsychotic polypharmacy in the treatment of schizophrenia
    Fleischhacker, W. Wolfgang
    Uchida, Hiroyuki
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 (07) : 1083 - 1093
  • [26] Lifetime suicide rates in treated schizophrenia: 1875-1924 and 1994-1998 cohorts compared
    Healy, D
    Harris, M
    Tranter, R
    Gutting, P
    Austin, R
    Jones-Edwards, G
    Roberts, AP
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2006, 188 : 223 - 228
  • [27] Mortality among patients with schizophrenia and reduced psychiatric hospital care
    Heilä, H
    Haukka, J
    Suvisaari, J
    Lönnqvist, J
    [J]. PSYCHOLOGICAL MEDICINE, 2005, 35 (05) : 725 - 732
  • [28] Pathways through care of severely mentally ill individuals experiencing multiple public crisis events: a qualitative description
    Hensen, Mariette J.
    de Mooij, Liselotte D.
    Theunissen, Jan
    Dekker, Jack
    Willemsen, Michael
    Zoeteman, Jeroen
    Peen, Jaap
    de Wit, Matty A. S.
    [J]. BMC PSYCHIATRY, 2016, 16
  • [29] Death by homicide, suicide, and other unnatural causes in people with mental illness: a population-based study
    Hiroeh, U
    Appleby, L
    Mortensen, PB
    Dunn, G
    [J]. LANCET, 2001, 358 (9299) : 2110 - 2112
  • [30] Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis
    Hjorthoj, Carsten
    Sturup, Anne Emilie
    McGrath, John J.
    Nordentoft, Merete
    [J]. LANCET PSYCHIATRY, 2017, 4 (04): : 295 - 301